Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Erythroid-Lineage Specific Engraftment in Patients with Severe Hemoglobinopathy Following Allogeneic Hematopoietic Stem Cell Transplantation.

Paul M. Armistead, MD, PhD, Mehrdad Mohseni, MD, Roslyn Gerwin, Masood Iravani, MD, Bahram Chardouli, Sharbano Rhostami, Ardeshir Ghavamzadeh, MD, Jerome Ritz, MD, Joseph H. Antin, MD, Catherine Wu, MD

Blood (2007) 110 (11): 2996.

https://doi.org/10.1182/blood.V110.11.2996.2996

Published: 2007

Journal Articles

Genome Wide Single Nucleotide Polymorphism Typing for Identification of Putative Minor Histocompatibility Antigens in Graft Versus Host Disease.

Ann Mullally, MD, Cheng Li, PhD, Haesook Kim, PhD, Mehrdad Mohseni, MD, Edwin P. Alyea, MD, Joseph H. Antin, MD, Robert J. Soiffer, MD, Jerome Ritz, MD

Blood (2006) 108 (11): 447.

https://doi.org/10.1182/blood.V108.11.447.447

Published: 2006

Journal Articles

IL-2 regulates FOXP3 expression in human CD4 + CD25 + regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo

Emmanuel Zorn, Erik A. Nelson, Mehrdad Mohseni, Fabrice Porcheray, Haesook Kim, Despina Litsa, Roberto Bellucci, Elke Raderschall, Christine Canning, Robert J. Soiffer, David A. Frank, Jerome Ritz

Blood (2006) 108 (5): 1571–1579.

https://doi.org/10.1182/blood-2006-02-004747

Published: 2006

Journal Articles

Post-Transplant Monitoring of Erythroid Lineage Specific Chimerism.

Paul Armistead, MD, PhD, Mehrdad Mohseni, MD, Roslyn Gerwin, Wandi Zhang, Masoud Iravani, MD, Ardeshir Ghavamzadeh, MD, Jerome Ritz, MD, Catherine Wu, MD

Blood (2005) 106 (11): 5233.

https://doi.org/10.1182/blood.V106.11.5233.5233

Published: 2005

Journal Articles

IL-2 Therapy Promotes the Expansion of Human CD4+CD25+ Regulatory T Cells and Selectively Upregulates the Expression of FOXP3 in T Cells In Vivo.

Emmanuel Zorn, PhD, Erik A. Nelson, PhD, Mehrdad Mohseni, MD, Despina Litsa, BSc, Haesook Kim, PhD, Roberto Bellucci, PhD, Fabrice Porcheray, PharmD, Christine Canning, MD, Robert J. Soiffer, MD, Jerome Ritz, MD

Blood (2005) 106 (11): 1257.

https://doi.org/10.1182/blood.V106.11.1257.1257

Published: 2005

NARROW

Erythroid-Lineage Specific Engraftment in Patients with Severe Hemoglobinopathy Following Allogeneic Hematopoietic Stem Cell Transplantation.

Genome Wide Single Nucleotide Polymorphism Typing for Identification of Putative Minor Histocompatibility Antigens in Graft Versus Host Disease.

IL-2 regulates FOXP3 expression in human CD4 + CD25 + regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo

Post-Transplant Monitoring of Erythroid Lineage Specific Chimerism.

IL-2 Therapy Promotes the Expansion of Human CD4+CD25+ Regulatory T Cells and Selectively Upregulates the Expression of FOXP3 in T Cells In Vivo.

Email alerts

ASH Publications

American Society of Hematology

Erythroid-Lineage Specific Engraftment in Patients with Severe Hemoglobinopathy Following Allogeneic Hematopoietic Stem Cell Transplantation.

Genome Wide Single Nucleotide Polymorphism Typing for Identification of Putative Minor Histocompatibility Antigens in Graft Versus Host Disease.

IL-2 regulates FOXP3 expression in human CD4 + CD25 + regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo

Post-Transplant Monitoring of Erythroid Lineage Specific Chimerism.

IL-2 Therapy Promotes the Expansion of Human CD4+CD25+ Regulatory T Cells and Selectively Upregulates the Expression of FOXP3 in T Cells In Vivo.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only